Chuck Klein Discusses Biosimilars at G-CEIP’s Professional Development Program

Partner Chuck Klein spoke at G-CEIP’s Intellectual Property for Industry and Academia Professionals: Training the Trainers November 14-15 at the GOA College of Pharmacy in Panaji Goa, India. Chuck presented on “Biosimilar Litigation in the United States.”  Additional topics discussed during the program included:

• Indirect Infringement in Pharmaceutical Patent Litigation
• Patent Invalidity
• Entrepreneurial Patent Management in Pharma Industry: Inter Partes Review (IPR)
• Patent Litigation: Recent Case Studies
• Intellectual Property Rights: Innovation, Economics & Access
• Conducting Patentability Search and Evaluating Results
• Pillars of Patent and Non-Registrable Patents in India
• Fundamentals of Trademark and Copyright

Chuck is chair of the firm’s Complex Commercial Litigation Practice and has significant experience with regard to the pharmaceutical and biotechnology industries. This includes litigating billion-dollar antitrust and patent issues for branded pharmaceutical companies, as well as representing generic drug manufacturers in high-stakes patent litigation brought under the Hatch-Waxman Act and in related regulatory proceedings before the Food and Drug Administration.